J&J Making Offer For J-Beauty Firm Ci:z Amid Throes Of Consumer Biz Revival
This article was originally published in The Rose Sheet
Johnson & Johnson intends to buy out Japan-based Ci:z Holdings for north of $2bn, which would give it full ownership of the firm’s dermocosmetic brand portfolio, including Dr.Ci:Labo, a standout performer for J&J’s beauty and larger consumer business in 2018.
You may also be interested in...
Johnson’s baby product sales picked up in the third quarter after a rough start as its baby care division sales up 20% in the US to $120m. US consumer health sales grew 6.6% to $1.37bn, also helped by total worldwide beauty sales increasing 6.5% to $1.08bn.
The overhaul in line with “modern parents’ preferences” could be what’s needed to rouse the sleepy brand and spur Consumer business growth.
CVS teamed with Peach & Lily founder Alicia Yoon to curate an assortment of offerings from South Korean skin-care brands and Yoon’s own Peach Slices line, rolling out to 2,100 doors nationwide in April. With Target, Ulta and Sephora also building their K-beauty offerings, mainstream players may face growing competition for shelf space as millennials gravitate to the quirky and fun, and away from science-driven anti-aging.